Management ChangeJun 18, 2026, 05:06 PM
MapLight Therapeutics CFO Separated; Interim Appointed
AI Summary
MapLight Therapeutics announced the immediate separation of its Chief Financial Officer, Vishwas Setia, on June 18, 2026, following a human resources violation. The company clarified that the separation was unrelated to its financial performance or internal controls. Mr. Setia will not receive severance but will get up to three months of COBRA health coverage. Jonathan Gillis, the company's Chief Administrative and Accounting Officer, has been appointed interim CFO and will continue his existing roles.
Key Highlights
- Vishwas Setia separated as Chief Financial Officer of MapLight Therapeutics, effective June 18, 2026.
- Separation was due to a human resources violation, unrelated to the company's financial or operating results.
- Mr. Setia is not entitled to severance payment.
- He will receive continued health coverage under COBRA for up to three months.
- Jonathan Gillis, Chief Administrative and Accounting Officer, was appointed interim CFO.
- Mr. Gillis will also continue as the company's principal accounting officer.
Price Impact
More from MPLT